PL414902A1 - Pharmaceutical composition containing combination of vitamin K1 and K2 and its application - Google Patents
Pharmaceutical composition containing combination of vitamin K1 and K2 and its applicationInfo
- Publication number
- PL414902A1 PL414902A1 PL414902A PL41490215A PL414902A1 PL 414902 A1 PL414902 A1 PL 414902A1 PL 414902 A PL414902 A PL 414902A PL 41490215 A PL41490215 A PL 41490215A PL 414902 A1 PL414902 A1 PL 414902A1
- Authority
- PL
- Poland
- Prior art keywords
- vitamin
- application
- pharmaceutical composition
- composition containing
- containing combination
- Prior art date
Links
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 title abstract 2
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 title abstract 2
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 title abstract 2
- 235000019175 phylloquinone Nutrition 0.000 title abstract 2
- 239000011772 phylloquinone Substances 0.000 title abstract 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 title abstract 2
- 229960001898 phytomenadione Drugs 0.000 title abstract 2
- 235000019143 vitamin K2 Nutrition 0.000 title abstract 2
- 239000011728 vitamin K2 Substances 0.000 title abstract 2
- 230000033558 biomineral tissue development Effects 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem zgłoszenia jest kompozycja farmaceutyczna, zawierająca połączenie witamin K1 i K2, gdzie witamina K1 występuje w ilości 25 µg - 300 µg, a witamina K2 występuje w ilości 10 µg - 45 µg oraz jej zastosowanie, w celu profilaktyki krwawień i zapewnienia prawidłowej mineralizacji tkanki kostnej u niemowląt karmionych piersią,.The subject of the application is a pharmaceutical composition containing a combination of vitamins K1 and K2, where vitamin K1 is in the amount of 25 µg - 300 µg, and vitamin K2 is in the amount of 10 µg - 45 µg and its use for the prevention of bleeding and ensuring the proper mineralization of bone tissue in breast-fed infants.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL414902A PL414902A1 (en) | 2015-11-23 | 2015-11-23 | Pharmaceutical composition containing combination of vitamin K1 and K2 and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL414902A PL414902A1 (en) | 2015-11-23 | 2015-11-23 | Pharmaceutical composition containing combination of vitamin K1 and K2 and its application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL414902A1 true PL414902A1 (en) | 2017-06-05 |
Family
ID=58793703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL414902A PL414902A1 (en) | 2015-11-23 | 2015-11-23 | Pharmaceutical composition containing combination of vitamin K1 and K2 and its application |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL414902A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700082678A1 (en) * | 2017-07-20 | 2017-10-20 | Gianfranco Caramelli | "Association of Salvia Miltiorrhiza Bunge and vitamins K1 and / or K2 for the treatment of various diseases related to alterations of osteogenesis" |
-
2015
- 2015-11-23 PL PL414902A patent/PL414902A1/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700082678A1 (en) * | 2017-07-20 | 2017-10-20 | Gianfranco Caramelli | "Association of Salvia Miltiorrhiza Bunge and vitamins K1 and / or K2 for the treatment of various diseases related to alterations of osteogenesis" |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018002990A (en) | USE OF PASTEURIZED AKKERMANSIA TO TREAT METABOLIC DISORDERS. | |
| MX391850B (en) | COMPOUNDS FOR USE IN THE TREATMENT OR AMENDING OF HUNTINGTON'S DISEASE | |
| CO2017005626A2 (en) | A composition comprising bacteroides thetaiotaomicron | |
| IL255203B (en) | Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders | |
| BR112015029611A2 (en) | compositions for use in cartilage rupture | |
| BR112018071831A2 (en) | synergistic anti-irritant taurine and aloe compositions and methods | |
| BR112018075140A2 (en) | composition in the form of an injectable aqueous solution, and single dose formulation at a pH of 7 to 7.8 | |
| MX2018002546A (en) | COMPOSITIONS THAT INCLUDE A UROLITINE COMPOUND. | |
| EA201991447A1 (en) | VISCOSITY REDUCTION OF PHARMACEUTICAL COMPOSITIONS | |
| CL2016002955A1 (en) | Sweetener composition comprising allulose and a stevia extract; food product or beverage comprising the sweetener composition; tabletop sweetener; use of the sweetener composition. | |
| BR112016013194A2 (en) | ORAL HYGIENE COMPOSITIONS COMPRISING CALCIUM CARBONATE AND SILICA | |
| MX2018004616A (en) | Cosmetic composition having probiotic bacteria. | |
| MX2017005812A (en) | Cleansing compositions. | |
| TR201908639T4 (en) | Saffron-based compositions for the prevention or treatment of degenerative eye disorders. | |
| BR112016019201A2 (en) | solid oral care compositions, teeth cleaning method and use of polyethylene oxide | |
| CR20190026A (en) | Vaginal composition comprising a combination of estrogen and vitamin d | |
| BR112018013501A2 (en) | use of a fermented ingredient and nondigestible oligosaccharide in the manufacture of a nutritional composition, method for enhancing immunoglobulin a secretion in a human subject aged 0 to 36, and method for enhancing mucosal immune defense in a human subject aged 0 to 36 months | |
| PH12016502386A1 (en) | Oral care compositions | |
| AR099863A1 (en) | METHOD FOR REDUCING THE RISK OF HYPERSENSITIVITY TO VISCERAL PAIN | |
| AR097678A1 (en) | COMPOSITION FOR ORAL CARE THAT INCLUDES A DILUTED GEL OF SODIUM AND CALCIUM ALGINATE | |
| PH12015502242A1 (en) | Lutein composition suitable for infant food formulations | |
| MX2020007894A (en) | Surface-reacted calcium carbonate for modifying the biomechanical properties of the skin. | |
| PL414902A1 (en) | Pharmaceutical composition containing combination of vitamin K1 and K2 and its application | |
| BR112019023944A2 (en) | pharmaceutical combination for the treatment of cancer | |
| PH12020550104A1 (en) | Salts of (r)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one |